June 7, 2019 — IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (PTCOG) conference, June 10-15 in Manchester, U.K. The company said myQA iON significantly reduces the time needed for patient quality assurance (QA) for proton therapy (PT).
The use of PT machine log files, process automation, task-based workflows and the latest web technologies in myQA iON significantly increase QA efficiency while ensuring patient treatment safety. Compared to conventional detector measurements (at isocenter), myQA iON enables a reduction of the QA measurement effort that results in a three times faster patient QA. This efficiency increase was confirmed by a global survey conducted amongst 37 practicing medical physicists at proton therapy centers.
“Combining irradiation logs and an independent dose recalculation with myQA iON, we intend to reduce the amount of measurements performed for patient QA by approximately 90 percent,” said Stefan Both, professor and head of medical physics at the Department of Radiation Oncology, University Medical Center Groningen, Netherlands.
myQA iON combines the analysis of irradiation log files and sophisticated high-accuracy Monte Carlo dose recalculation to provide the user with an independent QA dose calculation, as well as the ability to verify the quality and safety of each patient treatment fraction.
“The ability to automate our patient QA, and the flexibility to use irradiation log files, real dose measurements and Monte Carlo secondary recalculations in one system will bring us to a new level in PT treatment plan QA efficiency and accuracy,” said Zuofeng Li, physics director at the University of Florida Health Proton Therapy Institute, Jacksonville, Fla.
The software environment offers all patient QA tasks and workflow steps in a single interface. The latest web technologies allow users to access their patient QA anytime and anywhere within the hospital network. myQA iON supports patient QA for proton therapy machines of all major vendors.
myQA iON is currently undergoing U.S. Food and Drug Administration (FDA) 510(k) review.
For more information: www.iba-worldwide.com
April 18, 2024 
